Skip to content

PolitiKit

Lobbying by JN Nova Pharma Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Client of a consultant lobbyist

JN Nova Pharma Inc.

Meetings this Parliament
2
With MPs
0
Since Nov 2021
2
Active registrations
1

Most recent reported meeting: Oct 14, 2026.

Registrations in effect

Consultant In effect since Aug 3, 2026

Consultant Mitchell Goldie of Crestview Strategy

Consultant lobbyists

  • Mitchell Goldie Former designated public office holder

    Formerly Deputy Director, Special Projects, Liberal Research Bureau, House of Commons (2025–2025)

    Formerly Deputy Director of Strategic Research, Liberal Research Bureau, House of Commons (2024–2025)

    Formerly Manager of Strategic Research, Liberal Research Bureau, House of Commons (2024–2024)

    Formerly Senior Advisor, Liberal Research Bureau, House of Commons (2022–2024)

Institutions they may lobby: Finance Canada (FIN), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), National Research Council (NRC), Senate of Canada

What they're lobbying on (1)
  • Funding opportunities for the research and development of therapeutics for unmet medical needs under the Strategic Innovation Fund and/or other similar programs.

Registration 962022-387346-1. Look it up in the official Registry

Reported meetings

Spreadsheet

  • Reported by Mitchell Goldie · Consultant

    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Funding opportunities for the research and development of therapeutics for unmet medical needs under the Strategic Innovation Fund and/or other similar programs. Read more

    Official report

  • Reported by Mitchell Goldie · Consultant

    • Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
    Funding opportunities for the research and development of therapeutics for unmet medical needs under the Strategic Innovation Fund and/or other similar programs. Read more

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.